Article ; Online: Photoinduced Electron Transfer-Based Glutathione-Sensing Theranostic Nanoprodrug with Self-Tracking and Real-Time Drug Release Monitoring for Cancer Treatment.
ACS applied materials & interfaces
2024 Volume 16, Issue 6, Page(s) 6859–6867
Abstract: The rapid development of nanomedicine has considerably advanced precision therapy for cancer treatment. Superior to traditional chemotherapy, emerging theranostic nanoprodrugs can effectively realize inherent self-tracking, targeted drug delivery, ... ...
Abstract | The rapid development of nanomedicine has considerably advanced precision therapy for cancer treatment. Superior to traditional chemotherapy, emerging theranostic nanoprodrugs can effectively realize inherent self-tracking, targeted drug delivery, stimuli-triggered drug release, and reduced systemic toxicity of chemotherapeutic drugs. However, theranostic nanoprodrugs with real-time drug release monitoring have remained rare so far. In this work, we developed a new glutathione-responsive theranostic nanoprodrug with a high drug-loading content of 59.4 wt % and an average nanoscale size of 46 nm, consisting of the anticancer drug paclitaxel and a fluorescent imaging probe with a high fluorescence quantum yield, which are linked by a disulfide-based glutathione-sensitive self-immolating linker. The strong fluorescence emission of the fluorophore enables efficacious self-tracking and sensitive fluorescence "ON-OFF" glutathione sensing. Upon encountering high-level glutathione in cancer cells, the disulfide bond is cleaved, and the resulting linker halves spontaneously collapse into cyclic small molecules at the same pace, leading to the simultaneous release of the therapeutic drug and the fluorescence-OFF imaging probe. Thereby, the drug release process is efficiently monitored by the fluorescence change in the nanoprodrug. The nanoprodrugs exerted high cytotoxicity toward various cancer cells, especially for A549 and HEK-293 cells, in which the nanoprodrugs generated better therapeutic effects than free paclitaxel. Our work demonstrated a new modality of smart theranostic nanoprodrugs for precise cancer therapy. |
---|---|
MeSH term(s) | Humans ; Precision Medicine ; Cell Line, Tumor ; Drug Liberation ; Electrons ; HEK293 Cells ; Paclitaxel/pharmacology ; Paclitaxel/therapeutic use ; Theranostic Nanomedicine/methods ; Optical Imaging/methods ; Glutathione/metabolism ; Disulfides/therapeutic use ; Nanoparticles/chemistry ; Neoplasms/diagnostic imaging ; Neoplasms/drug therapy |
Chemical Substances | Paclitaxel (P88XT4IS4D) ; Glutathione (GAN16C9B8O) ; Disulfides |
Language | English |
Publishing date | 2024-02-01 |
Publishing country | United States |
Document type | Journal Article |
ISSN | 1944-8252 |
ISSN (online) | 1944-8252 |
DOI | 10.1021/acsami.3c16585 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.